跳至主導覽
跳至搜尋
跳過主要內容
國立陽明交通大學研發優勢分析平台 首頁
English
中文
首頁
人員
單位
研究成果
計畫
獎項
活動
貴重儀器
影響
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
胡瑜峰 Yu-Feng
教授
生物藥學研究所
h-index
h10-index
h5-index
9289
引文
53
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
5194
引文
35
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
1154
引文
18
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2005
2024
每年研究成果
概覽
指紋
網路
研究成果
(339)
類似的個人檔案
(6)
指紋
查看啟用 Yu-Feng Hu 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Keyphrases
Ablation
29%
Ablation Outcomes
9%
Ablation Therapy
5%
Activation Time
5%
Arrhythmia Management
5%
Arrhythmogenic Right Ventricular Cardiomyopathy
10%
Arrhythmogenic Right Ventricular Dysplasia
8%
Atrial Arrhythmia
7%
Atrial Fibrillation
97%
Atrial Fibrillation Ablation
27%
Atrial Fibrillation Recurrence
17%
Atrial Substrate
19%
Atrial Tachycardia
6%
Atrium
6%
Catheter Ablation
71%
CHA2DS2-VASc Score
15%
CHADS2 Score
5%
Clinical Characteristics
6%
Clinical Outcomes
6%
Complex Fractionated Atrial Electrograms
6%
Confidence Interval
11%
Drug Refractory
6%
Electrogram
9%
Electrophysiological Characteristics
12%
Endocardium
5%
Hazard Ratio
9%
High Incidence
5%
Ischemic Stroke
7%
Left Atrial
11%
Left Atrial Diameter
7%
Left Atrium
10%
National Cohort Study
11%
New-onset Atrial Fibrillation
5%
Non-paroxysmal Atrial Fibrillation
11%
Oral Anticoagulants
7%
Paroxysmal Atrial Fibrillation
29%
Persistent Atrial Fibrillation
15%
Pulmonary Vein
11%
Pulmonary Vein Isolation
25%
Radiofrequency Catheter Ablation
8%
Risk of Ischemic Stroke
6%
Scar
5%
Sinus Rhythm
10%
Stroke Risk
5%
Substrate Characteristics
5%
Substrate Properties
9%
Sudden Cardiac Death
7%
Taiwan
8%
Ventricular Arrhythmia
28%
Ventricular Tachycardia
8%
Medicine and Dentistry
Ablation Therapy
7%
Antithrombotic
10%
Apoplexy
13%
Arrhythmogenic Right Ventricular Dysplasia
15%
Atrial Electrogram
6%
Atrial Fibrillation
100%
Atrial Fibrillation Ablation
7%
Atrial Flutter
7%
Atrium
6%
Brain Ischemia
8%
Cardiac Dysrhythmia
10%
Cardiomyopathy
8%
Cardiovascular System
7%
Catheter Ablation
74%
Catheter Ablation
52%
CHA2DS2-VASc Score
12%
Cohort Analysis
9%
Electrocardiogram
8%
Electrography
14%
Endocardium
6%
Hazard Ratio
8%
Heart Failure
5%
Heart Rhythm
6%
Heart Ventricle Arrhythmia
19%
Left Atrium
11%
Paroxysmal Atrial Fibrillation
26%
Persistent Atrial Fibrillation
11%
Pulmonary Vein
14%
Pulmonary Vein Isolation
24%
Recurrent Disease
31%
Risk Stratification
6%
Sinus Rhythm
9%
Sudden Cardiac Death
7%
Supraventricular Tachycardia
8%
Ventricular Outflow Tract
6%
Ventricular Tachycardia
19%
